|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 8
Zeitschriftenartikel
Hofmann, Felix O.; Miksch, Rainer C.; Weniger, Maximilian; Keck, Tobias; Anthuber, Matthias; Witzigmann, Helmut; Nuessler, Natascha C.; Reissfelder, Christoph; Köninger, Jörg; Ghadimi, Michael; Bartsch, Detlef K.; Hartwig, Werner; Angele, Martin K.; D’Haese, Jan G. und Werner, Jens
(11. November 2022):
Outcomes and risks in palliative pancreatic surgery: an analysis of the German StuDoQ|Pancreas registry.
In: BMC Surgery, Bd. 22, Nr. 1
[PDF, 1MB]
Hofmann, Felix O. 
ORCID: https://orcid.org/0000-0002-6913-2429; Heinemann, Volker; D'Anastasi, Melvin; Gesenhues, Alena B.; Hesse, Nina; Weikersthal, Ludwig Fischer von; Decker, Thomas; Kiani, Alexander; Moehler, Markus; Kaiser, Florian; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Link, Hartmut; Modest, Dominik P.; Stintzing, Sebastian und Holch, Julian W.
(2022):
Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3/AIO KRK-0306.
In: European Radiology, Bd. 33, Nr. 2: S. 1174-1184
[PDF, 2MB]
ORCID: https://orcid.org/0000-0002-6913-2429; Heinemann, Volker; D'Anastasi, Melvin; Gesenhues, Alena B.; Hesse, Nina; Weikersthal, Ludwig Fischer von; Decker, Thomas; Kiani, Alexander; Moehler, Markus; Kaiser, Florian; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Link, Hartmut; Modest, Dominik P.; Stintzing, Sebastian und Holch, Julian W.
(2022):
Standard diametric versus volumetric early tumor shrinkage as a predictor of survival in metastatic colorectal cancer: subgroup findings of the randomized, open-label phase III trial FIRE-3/AIO KRK-0306.
In: European Radiology, Bd. 33, Nr. 2: S. 1174-1184
[PDF, 2MB]
Sirtl, Simon; Vornhuelz, Marlies; Hofmann, Felix O.; Mayerle, Julia und Beyer, Georg
(2022):
Pankreaskarzinom – Screening oder Surveillance: Was ergibt Sinn?
In: Gastroenterologie, Bd. 17, Nr. 6: S. 375-386
Kühn, Florian; Hasenhütl, Sandro Michael; Hofmann, Felix O.; Wirth, Ulrich; Drefs, Moritz; Werner, Jens und Schiergens, Tobias S.
(2022):
Endoscopic Vacuum Therapy for Left-Sided Colorectal Anastomotic Leak Without Fecal Diversion.
In: Diseases of the Colon & Rectum, Bd. 65, Nr. 3: S. 421-428
Froelich, Matthias F.; Petersen, Elina L.; Heinemann, Volker; Noerenberg, Dominik; Hesse, Nina; Gesenhues, Alena B.; Modest, Dominik P.; Sommer, Wieland H.; Hofmann, Felix O.; Stintzing, Sebastian und Holch, Julian W.
(2020):
Impact of Size and Location of Metastases on Early Tumor Shrinkage and Depth of Response in Patients With Metastatic Colorectal Cancer: Subgroup Findings of the Randomized, Open-Label Phase 3 Trial FIRE-3/AIO KRK-0306.
In: Clinical Colorectal Cancer, Bd. 19, Nr. 4: S. 291-300
Hofmann, Felix O.; Holch, Julian W.; Heinemann, Volker; Ricard, Ingrid; Reiser, Maximilian F.; Baumann, Alena B.; Hesse, Nina; D'Anastasi, Melvin; Modest, Dominik P.; Stintzing, Sebastian und Sommer, Wieland H.
(2018):
Prognostic value of radiologically enlarged lymph nodes in patients with metastatic colorectal cancer: Subgroup findings of the randomized, open-label FIRE-3/AIO KRK0306 trial.
In: European Journal of Radiology, Bd. 100: S. 124-129
Winter, Katharina S.; Hofmann, Felix O.; Thierfelder, Kolja M.; Holch, Julian W.; Hesse, Nina; Baumann, Alena B.; Modest, Dominik P.; Stintzing, Sebastian; Heinemann, Volker; Ricke, Jens; Sommer, Wieland H. und D'Anastasi, Melvin
(2018):
Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastases.
In: European Radiology, Bd. 28, Nr. 11: S. 4839-4848
Froelich, Matthias F.; Heinemann, Volker; Sommer, Wieland H.; Holch, Julian W.; Schöppe, Franziska; Hesse, Nina; Baumann, Alena B.; Kunz, Wolfgang G.; Reiser, Maximilian F.; Ricke, Jens; D'Anastasi, Melvin; Stintzing, Sebastian; Modest, Dominik P.; Kazmierczak, Philipp M. und Hofmann, Felix O.
(2018):
CT attenuation of liver metastases before targeted therapy is a prognostic factor of overall survival in colorectal cancer patients. Results from the randomised, open-label FIRE-3/AIO KRK0306 trial.
In: European Radiology, Bd. 28, Nr. 12: S. 5284-5292